Literature DB >> 2893934

Ursodeoxycholic acid in biliary atresia.

H Nittono, A Tokita, M Hayashi, N Nakatsu, K Obinata, T Watanabe, Y Yamashiro, K Yabuta, T Miyano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2893934     DOI： 10.1016/s0140-6736(88)91313-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  Oral bile acids in cystic fibrosis-associated liver disease.

Authors:  C Colombo; A Crosignani; M G Apostolo; M T Marzano; N Bettinardi; A Giunta
Journal:  J R Soc Med       Date:  1994       Impact factor: 5.344

2.  Inchin-ko-to prevents medium-term liver fibrosis in postoperative biliary atresia patients.

Authors:  Tsuyoshi Tamura; Hiroyuki Kobayashi; Atsuyuki Yamataka; Geoffrey J Lane; Hiroyuki Koga; Takeshi Miyano
Journal:  Pediatr Surg Int       Date:  2007-02-08       Impact factor: 1.827

Review 3.  Ursodeoxycholic acid in chronic liver disease.

Authors:  J S de Caestecker; R P Jazrawi; M L Petroni; T C Northfield
Journal:  Gut       Date:  1991-09       Impact factor: 23.059
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.